Deciphering of Candida parapsilosis induced immune response in Drosophila melanogaster

Virulence. 2021 Dec;12(1):2571-2582. doi: 10.1080/21505594.2021.1980989.

Abstract

Candida infections are the most prevalent cause of serious human mycoses and are the third most common pathogens isolated from bloodstream infections in hospitalized patients. C. parapsilosis is a member of the non-albicans spp., which have a predilection for causing life-threatening disease in neonates and hospitalized pediatric patients. In this study, we utilized a Drosophila melanogaster infection model to analyze the immunological responses to C. parapsilosis. Our results demonstrate that the Toll pathway in Drosophila controls C. parapsilosis proliferation as the Toll signaling mutant MyD88-/- flies are highly susceptible to C. parapsilosis. We also confirmed that the MyD88-/- fly is a convenient invertebrate animal model to analyze virulence properties of different species and strains from the C. parapsilosis sensu lato complex as C. orthopsilosis, C. metapsilosis proved to be less virulent than C. parapsilosis sensu stricto and the N-mannan deficient C. parapsilosis och1Δ/Δ strain showed attenuated pathogenicity in this immunodeficient Drosophila background. We also found that Persephone protease is not required for detection and activation of Toll pathway during C. parapsilosis infection. Furthermore, we observed that Drosophila β-glucan receptor deficient flies where more sensitive to C. parapsilosis compared to wild-type flies; however, we could not find a clear dependence on the recognition of this receptor and the cell wall β-glucan exposure-induced host response. These studies establish this D. melanogaster infection model as an efficient tool in deciphering immune responses to C. parapsilosis as well as for assessing virulence factors produced by this emerging fungal predator.

Keywords: Candida; Drosophila melanogaste; cell wall; innate immune response; recognition; systemic infection; virulence; β-glucan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Candida parapsilosis* / genetics
  • Child
  • Drosophila melanogaster*
  • Humans
  • Immunity
  • Myeloid Differentiation Factor 88

Substances

  • Antifungal Agents
  • Myeloid Differentiation Factor 88

Grants and funding

A.G. was supported by grants 20391 3/2018/FEKUSTRAT, Hungarian National Research, Development and Innovation Office (NKFIH K 123952). A.G. and K.Cs were additionally funded by the Momentum Grant by the Hungarian Academy of Sciences (LP2018-15/2018). This work was also funded and supported by GINOP-2.3.2.-15-2016-00035;H2020 European Institute of Innovation and Technology [739593]; Hungarian Scientific Research Fund [K123952]; Nemzeti Fejlesztési Minisztérium [by GINOP-2.3.2.-15-2016-00035]; Nemzeti Fejlesztési Minisztérium [20391 3/2018/FEKUSTRAT]; Magyar Tudományos Akadémia [LP2018-15/2018]